BRIACELL THERAPEUTICS CORP's ticker is BCTX and the CUSIP is 10778Y302. A total of 2 filers reported holding BRIACELL THERAPEUTICS CORP in Q3 2023. The put-call ratio across all filers is - and the average weighting 13.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $15,900 | -13.8% | 2,500 | 0.0% | 0.00% | – |
Q1 2023 | $18,450 | +70.0% | 2,500 | 0.0% | 0.00% | – |
Q4 2022 | $10,850 | -89.5% | 2,500 | -86.0% | 0.00% | – |
Q2 2022 | $103,000 | -93.5% | 17,800 | -88.7% | 0.00% | -100.0% |
Q1 2022 | $1,591,000 | +541.5% | 156,900 | +424.7% | 0.01% | +400.0% |
Q4 2021 | $248,000 | – | 29,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmond Asset Management, LLC | 136,593 | $1,106,000 | 0.35% |
Total Clarity Wealth Management, Inc. | 11,425 | $93,000 | 0.04% |
Virtu Financial LLC | 32,952 | $267,000 | 0.02% |
Apollon Wealth Management, LLC | 19,400 | $157,000 | 0.02% |
Summit Trail Advisors, LLC | 35,000 | $284,000 | 0.02% |
FNY Investment Advisers, LLC | 4,687 | $37,000 | 0.02% |
Freedom Investment Management, Inc. | 16,649 | $135,000 | 0.01% |
VOLORIDGE INVESTMENT MANAGEMENT, LLC | 156,946 | $1,271,000 | 0.01% |
Belvedere Trading LLC | 13,608 | $107,000 | 0.00% |
GOFEN & GLOSSBERG LLC /IL/ | 10,000 | $81,000 | 0.00% |